Strategic Initiative

Slingshot members are tracking this corporate initiative:

Ultragenyx and Takeda enter into a Collaboration to Develop and Commercialize Therapies for Rare Genetic Diseases

Source Link:
http://ir.ultragenyx.com/releasedetail.cfm?ReleaseID=974586

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
RARE Community voting in process
TKD.F Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Jun 07, 2016
Projected Implementation:
Q2, 2016
Relevance Tracked Until:
Q4, 2016
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Rare Genetic Diseases, Collaboration
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.